Worldwide activity and safety of bicalutamide: a summary review
- 1 January 1996
- Vol. 47 (1) , 70-79
- https://doi.org/10.1016/s0090-4295(96)80012-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancerUrology, 1995
- Testicular Histology after Treatment with the new Antiandrogen Casodex for Carcinoma of the ProstateScandinavian Journal of Urology and Nephrology, 1994
- Pathological and morphometric assessment of testicular parameters in patients with metastatic prostate cancer following treatment with either the antiandrogen Casodex (ZM176,334) or bilateral orchidectomyUrological Research, 1994
- Current clinical studies with a new nonsteroidal antiandrogen, casodexThe Prostate, 1994
- Casodex: A pure non-steroidal anti-androgen used as monotherapy in advanced prostate cancerThe Prostate, 1992
- Flutamide-Related Fulminant Hepatic FailureJournal of Clinical Gastroenterology, 1991
- Flutamide-induced liver failureJournal of Hepatology, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Casodex (ICI 176,334), A New, Non-Steroidal Anti-Androgen. Early Clinical ResultsHormone Research, 1989
- Flutamide as Primary Treatment for Metastatic Prostatic CancerBritish Journal of Urology, 1987